Statements (17)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:alsoKnownAs |
gptkb:sintilimab
|
| gptkbp:approvedBy |
gptkb:China
2018 |
| gptkbp:ATCCode |
L01FF10
|
| gptkbp:developedBy |
gptkb:Eli_Lilly
gptkb:Innovent_Biologics |
| gptkbp:drugClass |
PD-1 inhibitor
|
| https://www.w3.org/2000/01/rdf-schema#label |
Tyvyt
|
| gptkbp:indication |
gptkb:non-small_cell_lung_cancer
gptkb:classical_Hodgkin_lymphoma |
| gptkbp:mechanismOfAction |
immunotherapy
|
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:target |
PD-1 (programmed cell death protein 1)
|
| gptkbp:bfsParent |
gptkb:sintilimab
gptkb:Sintilimab |
| gptkbp:bfsLayer |
7
|